Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

RIGL - Rigel Pharmaceuticals

IEX Last Trade
13.45
-0.100   -0.743%

Share volume: 100,019
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$13.55
-0.10
-0.74%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
35%
Profitability 43%
Dept financing 25%
Liquidity 34%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
7.69%
1 Month
26.32%
3 Months
43.51%
6 Months
-13.29%
1 Year
10.16%
2 Year
-2.61%
Key data
Stock price
$13.45
P/E Ratio 
-16.62
DAY RANGE
N/A - N/A
EPS 
-$0.81
52 WEEK RANGE
$7.12 - $17.30
52 WEEK CHANGE
$0.14
MARKET CAP 
236.476 M
YIELD 
N/A
SHARES OUTSTANDING 
17.595 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$120,103
AVERAGE 30 VOLUME 
$113,595
Company detail
CEO: Raul Rodriguez
Region: US
Website: https://www.rigel.com/
Employees: 280
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.

Recent news